Bryce Point Capital’s Nurix Therapeutics NRIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-28,564
Closed -$538K 364
2024
Q4
$538K Buy
+28,564
New +$538K 0.16% 214